Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

JPM15: Abbott Eyes Emerging Markets Only For Branded Generics Biz

This article was originally published in PharmAsia News

Executive Summary

Just in case the sight of Abbott divesting its branded generics businesses in developed markets to Mylan was not a clear enough signal of the company’s intention to focus solely on emerging markets, Michael J. Warmuth , the EVP with responsibility for the business, took the opportunity to spell it out at the recent JP Morgan Healthcare conference.

Topics

Related Companies

UsernamePublicRestriction

Register

SC088372

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel